IRIS - Res&Arch Institutional Research Information System - Research & Archive

BELLOMO, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.573
AS - Asia 1.029
EU - Europa 666
SA - Sud America 181
Continente sconosciuto - Info sul continente non disponibili 52
AF - Africa 40
OC - Oceania 6
Totale 3.547
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.499
SG - Singapore 439
IT - Italia 228
CN - Cina 166
HK - Hong Kong 141
BR - Brasile 134
RU - Federazione Russa 103
DE - Germania 69
VN - Vietnam 65
IE - Irlanda 59
KR - Corea 48
FR - Francia 43
BD - Bangladesh 38
CA - Canada 38
GB - Regno Unito 38
FI - Finlandia 27
IN - India 24
JP - Giappone 20
NL - Olanda 20
AR - Argentina 15
IL - Israele 14
TR - Turchia 14
IQ - Iraq 13
RO - Romania 12
SC - Seychelles 12
PL - Polonia 11
VE - Venezuela 10
ES - Italia 9
SE - Svezia 9
ZA - Sudafrica 9
AT - Austria 8
CO - Colombia 6
EC - Ecuador 5
GT - Guatemala 5
ID - Indonesia 5
MX - Messico 5
NZ - Nuova Zelanda 5
PK - Pakistan 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
CR - Costa Rica 4
CW - ???statistics.table.value.countryCode.CW??? 4
JM - Giamaica 4
PY - Paraguay 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
UA - Ucraina 4
IS - Islanda 3
KE - Kenya 3
LT - Lituania 3
MY - Malesia 3
NI - Nicaragua 3
NP - Nepal 3
PR - Porto Rico 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
BY - Bielorussia 2
CL - Cile 2
HN - Honduras 2
LB - Libano 2
MA - Marocco 2
MD - Moldavia 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CM - Camerun 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GM - Gambi 1
GP - Guadalupe 1
GY - Guiana 1
HR - Croazia 1
HT - Haiti 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MM - Myanmar 1
PA - Panama 1
PG - Papua Nuova Guinea 1
RE - Reunion 1
RS - Serbia 1
SD - Sudan 1
Totale 3.493
Salva come PNG Salva come JPEG
Città #
Singapore 323
San Jose 234
Ashburn 156
Hong Kong 137
Chandler 83
Council Bluffs 62
Santa Clara 61
Dublin 58
Boardman 57
Los Angeles 48
Seoul 48
Dallas 39
Perugia 38
Moscow 36
Beijing 34
New York 34
Milan 33
Lauterbourg 32
The Dalles 31
Phoenix 29
Piscataway 26
Munich 24
Ho Chi Minh City 19
North Bergen 19
Tokyo 19
San Mateo 18
Rome 17
Brooklyn 15
Hanoi 14
São Paulo 14
Altamura 12
Denver 12
Carrboro 11
Helsinki 11
Nuremberg 11
Turku 11
Princeton 10
Timisoara 10
Wilmington 10
Buffalo 9
Charlotte 9
Chennai 9
Lawrence 9
Medford 9
Montreal 9
Boston 8
London 8
Naples 8
Warsaw 8
Atlanta 7
Chicago 7
Da Nang 7
Frankfurt am Main 7
Hefei 7
Houston 7
Toronto 7
Amsterdam 6
Newark 6
Orem 6
Redmond 6
Turin 6
Vienna 6
Andover 5
Auckland 5
Baghdad 5
Columbus 5
Dong Ket 5
Falkenstein 5
Falls Church 5
Lappeenranta 5
Manchester 5
Poplar 5
Rio de Janeiro 5
Riverbank 5
Stockholm 5
Curitiba 4
Florence 4
Genoa 4
Johannesburg 4
New Orleans 4
Secaucus 4
Caracas 3
Des Moines 3
Groningen 3
Guatemala City 3
Kingston 3
Las Vegas 3
Managua 3
Mexico City 3
Miami 3
Mississauga 3
Mumbai 3
Newquay 3
Pittsburgh 3
San José 3
Shanghai 3
Tashkent 3
Vancouver 3
Willemstad 3
Abbeville 2
Totale 2.172
Salva come PNG Salva come JPEG
Nome #
Identification of natural products able to counteract the formation of advanced glycation end-products (AGEs) sustaining muscle atrophy 160
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 147
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 130
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 122
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 122
Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease 111
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward 109
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? 105
Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: Disease staging by NF-L, p-tau181, and GFAP 96
Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer's Disease 96
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays 95
Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid 95
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay 94
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics 94
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease 93
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum 91
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview 90
An unbalanced synaptic transmission: Cause or consequence of the amyloid oligomers neurotoxicity? 89
Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias 85
CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases 84
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's disease 83
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease 83
Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD 82
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts 82
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease 79
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers 79
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment 78
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 75
The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis 74
Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer’s disease biomarkers 73
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 71
LRRK2 Quantification in Cerebrospinal Fluid of Patients with Parkinson's Disease and Atypical Parkinsonian Syndromes 70
Blood-based biomarkers for Alzheimer’s disease: influence of kidney function 69
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions 68
Research advancement in fluid biomarkers for Parkinson's disease 65
Lipoproteins and α-synuclein in cerebrospinal fluid in Parkinson's disease: "Dangerous liaisons" on the road to neurodegeneration? 50
Studying Alzheimer's disease through an integrative serum metabolomic and lipoproteomic approach 44
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders 44
Diet-Derived Advanced Glycation End-Products (AGEs) Induce Muscle Wasting In Vitro, and a Standardized Vaccinium macrocarpon Extract Restrains AGE Formation and AGE-Dependent C2C12 Myotube Atrophy 39
Phosphorylated α-synuclein in CSF and plasma does not reflect synucleinopathy 37
Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer’s disease and Parkinson’s disease 33
Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers 32
Cerebrospinal fluid α-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's disease 29
Totale 3.547
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.272
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.272
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202251 0 0 0 0 2 5 4 13 4 7 7 9
2022/2023259 9 60 8 17 19 22 0 20 91 1 8 4
2023/2024223 10 16 12 6 7 1 34 6 49 11 27 44
2024/2025680 7 55 51 37 54 44 55 66 115 43 101 52
2025/20261.545 95 119 62 197 208 131 252 77 146 143 75 40
2026/2027743 51 62 172 372 86 0 0 0 0 0 0 0
Totale 3.547